Article

DC briefing boosts collaborative effort

Washington, DC-A congressional briefing held recently at the National Eye Institute (NEI) of the National Institutes of Health has highlighted the need for research partnerships to fight diabetic retinopathy effectively.

Washington, DC-A congressional briefing held recently at the National Eye Institute (NEI) of the National Institutes of Health has highlighted the need for research partnerships to fight diabetic retinopathy effectively.

The briefing featured Thomas W. Gardner, MD, MS, a diabetes researcher, clinician, and professor of ophthalmology and cellular and molecular physiology at the Pennsylvania State University Milton S. Hershey Medical Center, part of the Diabetic Retinopathy Clinical Research Network.

During the 1-day event, Dr. Gardner met with Rep. Gene Green (D-TX), a co-chairman of the Congressional Vision Caucus with NIH oversight, as well as senators Arlen Specter and Rick Santorum (both R-PA).

The network includes 545 experts at 163 clinical sites in 43 states and is one of several collaborative efforts funded by the NEI over the past 30 years to study diabetic retinopathy.

These networks have led to effective diabetic retinopathy treatments that have reduced blindness by 90% and saved $1.6 billion annually in health-care costs, the NEI said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.